ArshadMohammadKhananiMD

PubMed

• 2 citations
  Gene therapy for neovascular age-related macular degeneration by subretinal delivery of RGX-314: a phase 1/2a dose-escalation study.
  Robert Avery, David M Brown, Jeffrey S Heier, Stephen Pakola, Charles C Wykoff, Sherri Van Everen, Peter A Campochiaro, Allen C Ho, Stephen M Huddleston, Glenn J Jaffe...> ;Lancet. 2024 Mar 27
• Suprachoroidal Space Injection Technique: Expert Panel Guidance.
  Cunningham, E., Ciulla, T., Wykoff, C., Avery, R., Barakat, M., Boyer, D., Brown, D., Brucker, A., Heier, J., Holekamp, N., Kaiser, P., Khanani, A., Kim, J., Demirci, ...> ;Retina. 2024 Mar 5
• Compartmental Exudative Dynamics in Neovascular Age-Related Macular Degeneration: Volumetric Outcomes and Impact of Volatility in a Phase III Clinical Trial.
  Justis P Ehlers, Leina M Lunasco, Sari Yordi, Hasan Cetin, Thuy K Le, Kubra Sarici, Peter K Kaiser, Arshad M Khanani, Katherine E Talcott, Joanne Hu, Xiangyi Meng, Sun...> ;Ophthalmology. Retina. 2024 Feb 23
• 1 citations
  TENAYA and LUCERNE: Two-Year Results from the Phase 3 Neovascular Age-Related Macular Degeneration Trials of Faricimab with Treat-and-Extend Dosing in Year 2.
  Arshad M Khanani, Aachal Kotecha, Andrew Chang, Shih-Jen Chen, Youxin Chen, Robyn Guymer, Jeffrey S Heier, Frank G Holz, Tomohiro Iida, Jane A Ives, Jennifer I Lim, Hu...> ;Ophthalmology. 2024 Feb 19
• Two studies to learn if avacincaptad pegol works and is safe in people with geographic atrophy: a plain language summary of the GATHER1 and GATHER 2 studies.
  Jaffe, G., Khanani, A.> ;Immunotherapy. 2024 Mar 1
• Efficacy and Safety of Faricimab for Macular Edema due to Retinal Vein Occlusion: 24-Week Results from the BALATON and COMINO Trials.
  Tadayoni, R., Paris, L., Danzig, C., Abreu, F., Khanani, A., Brittain, C., Lai, T., Haskova, Z., Sakamoto, T., Kotecha, A., Schlottmann, P., Liu, Y., Seres, A., Retier...> ;Ophthalmology. 2024 Jan 26
• Bispecific VEGF-A and Angiopoietin-2 Antagonist RO-101 Preclinical Efficacy in Model of Neovascular Eye Disease.
  Li Xu, Jessi R Prentice, Raul Velez-Montoya, Alina Sinha, Mark R Barakat, Ashwin Gupta, Robert Lowenthal, Arshad M Khanani, Peter K Kaiser, Jeffrey S Heier, Anthony Jo...> ;Ophthalmology Science. 2024 Jan 18
• Review of real-world evidence of dual inhibition of VEGF-A and ANG-2 with faricimab in NAMD and DME.
  Chand, A., Khan, M., Fernando M Penha, Maliha Masud, Zoha A Khanani, Mathew Thomas, Rodney D Fong, Kyler Smith, Avishay Chand, Greggory Gahn, Gustavo Barreto Melo, Ars...> ;International Journal of Retina and Vitreous. 2024 Jan 17
• 2 citations
  Safety and efficacy of ixoberogene soroparvovec in neovascular age-related macular degeneration in the United States (OPTIC): a prospective, two-year, multicentre phas...
  Boyer, D., Wykoff, C., Busbee, B., Danzig, C., Joondeph, B., Major, J., Turpcu, A., Kiss, S., Khanani, A., Regillo, C., Pieramici, D.> ;Eclinicalmedicine. 2024 Jan 1
• Can intravitreal injections with higher volume cause higher intraocular eye pressure? Considerations for anti-complement injections in normal and glaucomatous eyes.
  Meyer, C., Melo, G., Khanani, A.> ;International Journal of Retina and Vitreous. 2023 Dec 14
• Gains in the current understanding of managing neovascular AMD with brolucizumab.
  Bahram Bodaghi, Arshad M Khanani, Ramin Khoramnia, Carlos Pavesio, Quan Dong Nguyen> ;Journal of Ophthalmic Inflammation and Infection. 2023 Nov 23
• 1 citations
  PIGMENT EPITHELIAL DETACHMENT THICKNESS AND VARIABILITY AFFECTS VISUAL OUTCOMES IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
  David Sarraf, Arshad M Khanani, SriniVas R Sadda, Andrew Chang, David T Wong, Anne-Sophie Kempf, Insaf Saffar, Shuhan Tang, Ramin Tadayoni> ;Retina. 2024 Jan 1
• 15 citations
  Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial.
  Arshad M Khanani, Sunil S Patel, Giovanni Staurenghi, Ramin Tadayoni, Carl J Danzig, David A Eichenbaum, Jason Hsu, Charles C Wykoff, Jeffrey S Heier, David R Lally, J...> ;Lancet. 2023 Oct 21
• Comparative assessment of subretinal hyper-reflective material in patients treated with brolucizumab versus aflibercept in HAWK and HARRIER.
  SriniVas Sadda, David Sarraf, Arshad M Khanani, Ramin Tadayoni, Andrew A Chang, Insaf Saffar, Kinfemichael Gedif, David T Wong> ;The British Journal of Ophthalmology. 2023 Sep 5
• Exudation in Patients With Neovascular Age-Related Macular Degeneration Treated With the Port Delivery System or Monthly Injections.
  Anam Akhlaq, David Williams, W Lloyd Clark, Hannah Khan, Arshad M Khanani, Lisa Walden, Carl Awh, J Taylor Graff, Jordan M Graff, Taku Wakabayashi, Carl Regillo, Katie...> ;American Journal of Ophthalmology. 2024 Feb 1
• 1 citations
  Anti-VEGF and steroid combination therapy relative to anti-VEGF mono therapy for the treatment of refractory DME: A systematic review of efficacy and meta-analysis of ...
  Amin Hatamnejad, Samantha Orr, Rohan Dadak, Arshad Khanani, Rishi Singh, Netan Choudhry> ;Acta Ophthalmologica. 2024 May 1
• 2 citations
  Correction: Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 18-month findings from the GATHER1 trial.
  Sunil S Patel, David R Lally, Jason Hsu, Charles C Wykoff, David Eichenbaum, Jeffrey S Heier, Glenn J Jaffe, Keith Westby, Dhaval Desai, Liansheng Zhu, Arshad M Khanani> ;Eye. 2023 Dec 1
• 5 citations
  Home vision monitoring in patients with maculopathy: current and future options for digital technologies.
  Konstantinos Balaskas, Faye Drawnel, Arshad M Khanani, Paul C Knox, George Mavromaras, Yi-Zhong Wang> ;Eye. 2023 Oct 1
• 24 citations
  Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 18-month findings from the GATHER1 trial.
  Sunil S Patel, David R Lally, Jason Hsu, Charles C Wykoff, David Eichenbaum, Jeffrey S Heier, Glenn J Jaffe, Keith Westby, Dhaval Desai, Liansheng Zhu, Arshad M Khanani> ;Eye. 2023 Dec 1
• 3 citations
  RETINAL VASCULITIS OR VASCULAR OCCLUSION AFTER BROLUCIZUMAB FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: A Systematic Review of Real-World Evidence.
  Charles C Wykoff, Hidetaka Matsumoto, Mark R Barakat, Helene Karcher, Anthony Lozama, Andrew Mayhook, Olorunfemi A Oshagbemi, Olessia Zorina, Tarek S Hassan, Arshad M ...> ;Retina. 2023 Jul 1
• 3 citations
  Biosimilars for retinal diseases: United States-Europe awareness survey (Bio-USER - survey).
  Ashish Sharma, Frank G Holz, Carl D Regillo, K Bailey Freund, David Sarraf, Arshad M Khanani, Caroline Baumal, Nancy Holekamp, Ramin Tadayoni, Nilesh Kumar, Nikulaa Pa...> ;Expert Opinion on Biological Therapy. 2023 Feb 19
• 3 citations
  Port delivery system with ranibizumab (Susvimo) recall- What does it mean to the retina specialists.
  Ashish Sharma, Arshad M Khanani, Nikulaa Parachuri, Nilesh Kumar, Francesco Bandello, Baruch D Kuppermann> ;International Journal of Retina and Vitreous. 2023 Jan 30
• 8 citations
  Emerging Treatment Options for Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration.
  Hannah Khan, Humza Sulahria, Huma Khan, Abrahim Ahmed, Netan Choudhry, Raja Narayanan, Carl Danzig, Arshad M Khanani, Aziz, A., Aamir A Aziz> ;Clinical Ophthalmology. 2023 Jan 1
• 1 citations
  Cooling Anesthesia for Intravitreal Injections - A Review.
  Priya R Chandrasekaran, Hannah Khan, Arshad M Khanani, Aziz, A., Aamir A Aziz> ;Clinical Ophthalmology. 2023 Jan 1
• 2 citations
  Impact of Modifying Abicipar Manufacturing Process in Patients with Neovascular Age-Related Macular Degeneration: MAPLE Study Results.
  David Callanan, Rahul N Khurana, Raj K Maturi, Sunil Patel, Charles C Wykoff, David Eichenbaum, Arshad M Khanani, Tarek Hassan, Hanh Badger, Shraddha Mehta, Grace Le, ...> ;Clinical Ophthalmology. 2023 Jan 1
• Join now to see all

Journal Articles

• Efficacy of Every Four Monthly and Quarterly Dosing of Faricimab vs Ranibizumab in Neovascular Age-Related Macular Degeneration  
  Arshad M Khanani, Sunil S Patel, Philip J Ferrone, Pravin U Dugel, JAMA Ophthalmology